Author details

Full Name

Abraham G Hartzema

Affiliation

ORCID

Career Start Year

1981

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36642778	Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.		2023
35509385	Drug absorption in bariatric surgery patients: A narrative review.	Health Science Reports	2022
35840690	Comparative Safety of Sleeve Gastrectomy and Roux-en-Y: A Propensity Score Analysis.	World J Surg	2022
33714616	US national trends in bariatric surgery: A decade of study.	Surgery	2021
31468265	Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy.	Dig Dis Sci	2020
32419226	Challenges facing drug utilization research in the Latin American region.	Pharmacoepidemiology and Drug Safety	2020
31883739	Metabolic syndrome and metabolically healthy status in adults with overweight or obesity, expressing no desire to lose weight.	Obesity Research and Clinical Practice	2020
31361913	Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015.	Pharmacotherapy	2019
30590306	Decline in dopamine agonists prescribing and characteristics of drugs prescribed during ambulatory office visits for restless legs syndrome: the National Ambulatory Medical Care Survey 2007-2015.	Sleep Medicine	2019
30839057	Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy.	Inflammatory Bowel Diseases	2019
29530369	Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome.	Sleep Medicine	2018
29936394	Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study.	Journal of Affective Disorders	2018
30170146	Association Between Recombinant Human Bone Morphogenetic Proteins and Postoperative Opioid Use in Lumbar Fusion Procedure Patients: A Propensity Score-Matched Analysis.	World Neurosurg	2018
27687215	Comments on prenatal diethylstilbestrol exposure andÂ high-grade squamous cell neoplasia of the lowerÂ genital tract.	American Journal of Obstetrics and Gynecology	2017
28672324	High Generic Drug Prices and Market Competition: A Retrospective Cohort Study.	Ann Intern Med	2017
28525295	Duration of Reproductive Years and the Risk of Cardiovascular and Cerebrovascular Events in Older Women: Insights from the National Health and Nutrition Examination Survey.	Journal of Women's Health	2017
28652320	Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.	American Journal of Health-System Pharmacy	2017
29281576	Prices of Generic Drugs Associated with Numbers of Manufacturers.	N Engl J Med	2017
28061833	Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model.	BMC Pregnancy Childbirth	2017
26597624	Stimulant use following the publicity of cardiovascular safety and the introduction of patient medication guides.	Pharmacoepidemiology and Drug Safety	2016
27137884	Comparison of Utilization and Clinical Outcomes for Belatacept- and Tacrolimus-Based Immunosuppression in Renal Transplant Recipients.	American Journal of Transplantation	2016
26136091	Erratum to: A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.	Drug Safety	2015
25653296	Antiepileptic drug use by pregnant women enrolled in Florida Medicaid.	Neurology	2015
25773561	Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink.	Value in Health	2015
26055920	A Comparative Assessment of Observational Medical Outcomes Partnership and Mini-Sentinel Common Data Models and Analytics: Implications for Active Drug Safety Surveillance.	Drug Safety	2015
24985530	Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.	Drug Saf	2014
24311725	Pediatric exclusivity: evolving legislation and novel complexities within pediatric therapeutic development.	Ann Pharmacother	2014
24300046	Is fidaxomicin worth the cost? The verdict is still out!	Clinical Infectious Diseases	2014
23648805	Evaluating the impact of database heterogeneity on observational study results.	Am J Epidemiol	2013
24166231	A comparison of the empirical performance of methods for a risk identification system.	Drug Saf	2013
24166223	Managing data quality for a drug safety surveillance system.	Drug Saf	2013
24166222	Defining a reference set to support methodological research in drug safety.	Drug Saf	2013
24166220	Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.	Drug Saf	2013
24192967	Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology.	BMJ, The	2013
23311996	Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines.	Gynecological Endocrinology	2013
23665270	Male breast cancer and 5Î±-reductase inhibitors finasteride and dutasteride.	Journal of Urology	2013
23413215	Response to comment on 'empirical assessment of methods for risk identification in healthcare data'.	Stat Med	2013
23574590	Drospirenone and non-fatal venous thromboembolism: is there a risk difference by dosage of ethinyl-estradiol?	Journal of Thrombosis and Haemostasis	2013
23209115	Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis.	CMAJ	2013
23734036	Risk of acute kidney injury associated with the use of fluoroquinolones.	CMAJ	2013
22037893	Validation of a common data model for active safety surveillance research.	J Am Med Inform Assoc	2012
22690127	Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting.	Journal of Asthma and Allergy	2012
23015364	Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.	Stat Med	2012
23316379	Transfusion practices in the management of sickle cell disease: a survey of Florida hematologists/oncologists.	ISRN Hematol	2012
21847800	Utilizing Medicare claims data for realâ¿time drug safety evaluations:is it feasible?	Pharmacoepidemiology and Drug Safety	2011
21922530	Hydroxyurea use in patients with sickle cell disease in a Medicaid population.	Am J Hematol	2011
20880757	Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?	Epilepsy and Behavior	2010
21041580	Advancing the science for active surveillance: rationale and design for the Observational Medical Outcomes Partnership.	Ann Intern Med	2010
19331257	Development and evaluation of a patient empowerment video to promote hydroxyurea adoption in sickle cell disease.	J Natl Med Assoc	2009
19691540	Lives in isolation: stories and struggles of low-income African American women with panic disorder.	CNS Neuroscience and Therapeutics	2009